Skip to search formSkip to main contentSkip to account menu

EGIS 3886

Known as: EGIS-3886, EGIS3886 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
SummaryThe time related distribution and pharmacokinetics of double-labelled EGIS-3886 (EGIS-3886-phenyl-14C and-ethyl-3H) were… 
1999
1999
Abstract The influence of serotonergic and benzodiazepine type anxiolytic drugs on the cortical activation and sleep-wakefulness… 
1999
1999
The distribution of 3H‐labelled deramciclane (EGIS‐3886), a new 5‐HT2 antagonist with anxiolytic activity, has been investigated… 
1999
1999
The synthesis, stereostructure, and enantiomeric separation by chromatography of a new, chiral anxiolytic agent, deramciclane… 
1999
1999
Ionization and lipophilicity of deramciclane hydrogenfumarate (EGIS-3886), a novel anxiolytic compound being under clinical trial… 
1998
1998
The absorption of deramciclane fumarate ((1R,2S,4R)-(-)-N,N-dimethyl-2-[(1,7,7-trimethyl-2-phenylbicyclo [2,2,1] hept-2-yl) oxy… 
1998
1998
The pharmacokinetics of deramciclane (CAS 120444-78-8, EGIS-3886) was investigated in rabbits after i.v., p.o. and s.c…